NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

PDS Biotechnology Corporation (NASDAQ: PDSB)

 
PDSB Technical Analysis
1.5
As on 9th Jun 2023 PDSB STOCK Price closed @ 5.90 and we RECOMMEND Buy for LONG-TERM with Stoploss of 5.26 & Sell for SHORT-TERM with Stoploss of 6.62 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

PDSBSTOCK Price

Open 5.82 Change Price %
High 5.96 1 Day 0.08 1.37
Low 5.51 1 Week -3.68 -38.41
Close 5.90 1 Month -0.18 -2.96
Volume 1039300 1 Year -3.08 -34.30
52 Week High 13.20 | 52 Week Low 2.97
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
PDSB
Daily Charts
PDSB
Intraday Charts
Whats New @
Bazaartrend
PDSB
Free Analysis
 
PDSB Important Levels Intraday
RESISTANCE6.77
RESISTANCE6.49
RESISTANCE6.32
RESISTANCE6.15
SUPPORT5.65
SUPPORT5.48
SUPPORT5.31
SUPPORT5.03
 
PDSB Forecast May 2024
4th UP Forecast11.58
3rd UP Forecast9.76
2nd UP Forecast8.63
1st UP Forecast7.51
1st DOWN Forecast4.29
2nd DOWN Forecast3.17
3rd DOWN Forecast2.04
4th DOWN Forecast0.22
 
PDSB Weekly Forecast
4th UP Forecast8.66
3rd UP Forecast7.77
2nd UP Forecast7.23
1st UP Forecast6.68
1st DOWN Forecast5.12
2nd DOWN Forecast4.57
3rd DOWN Forecast4.03
4th DOWN Forecast3.14
 
PDSB Forecast2024
4th UP Forecast26.63
3rd UP Forecast19.98
2nd UP Forecast15.87
1st UP Forecast11.76
1st DOWN Forecast0.04
2nd DOWN Forecast-4.07
3rd DOWN Forecast-8.18
4th DOWN Forecast-14.83
 
 
PDSB Other Details
Segment EQ
Market Capital 343359488.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
PDSB Address
PDSB
 
PDSB Latest News
 
Your Comments and Response on PDS Biotechnology Corporation
 
PDSB Business Profile
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical cancer. The company is also developing various product candidates, which are in preclinical trials, including PDS0102 T-cell receptor gamma alternate reading frame protein (TARP) for treating prostate and breast cancers; PDS0103 (MUC-1) for ovarian, colorectal, lung, and breast cancers; and PDS0104, which include Tyrosinase-related protein 2 for the treatment of melanoma. In addition, it is developing PDS0201 for treating tuberculosis; PDS0202, an influenza vaccine candidate; and PDS0203, a vaccine for the prevention of COVID-19. The company has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. PDS Biotechnology Corporation was founded in 2005 and is based in Florham Park, New Jersey. Address: 25B Vreeland Road, Florham Park, NJ, United States, 07932
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service